174 filings
Page 3 of 9
424B3
u0dx8faeh4qi10a10
7 Apr 23
Prospectus supplement
5:20pm
EFFECT
hzxy 0ch7710
7 Apr 23
Notice of effectiveness
12:15am
ARS
nidpcoz
6 Apr 23
Annual report to shareholders
5:24pm
DEFA14A
5a04g
6 Apr 23
Additional proxy soliciting materials
5:23pm
424B3
4oi6d6
6 Apr 23
Prospectus supplement
5:15pm
EFFECT
zd3d2hrq
6 Apr 23
Notice of effectiveness
12:15am
8-K
xzsn09b1
5 Apr 23
Departure of Directors or Certain Officers
4:19pm
POS AM
viwvm9hqbc3i dz1
31 Mar 23
Prospectus update (post-effective amendment)
4:52pm
424B5
hp7t3sszpt4tnz rzz9a
31 Mar 23
Prospectus supplement for primary offering
9:11am
POS AM
ke39mi4hn4d
31 Mar 23
Prospectus update (post-effective amendment)
9:09am
S-8
gf58kzv7r9ykjo
31 Mar 23
Registration of securities for employees
6:49am
424B3
234sj l8s2693y
23 Mar 23
Prospectus supplement
8:07am
424B3
49x1db729kelass8itl3
23 Mar 23
Prospectus supplement
8:04am
8-K
vh3b81lz7sx15w5lgc
23 Mar 23
Other Events
8:01am
8-K
j6ktf3rlc
22 Mar 23
Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress
4:30pm
424B3
bcybl64 x1bme
5 Jan 23
Prospectus supplement
5:20pm
424B3
jy2qkl
5 Jan 23
Prospectus supplement
5:19pm
8-K
paiy 1v2x8l0
5 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:32pm